Nebenwirkungen · Insuman
Insuman Rapid 40 IU/ml solution for injection in a vial Insuman Rapid 100 IU/ml solution for injection in a vial · Abschnitt 4.8 · PDF-Seite 7
HOS-088601 · Präparat HOS-083671
MedDRA system Common Uncommon Not known organ classes Immune system Shock Immediate type disorders allergic reactions (hypotension, angioneurotic oedema, bronchospasm, generalised skin reactions); Anti-insulin antibodies Metabolism and Oedema Hypoglycaemia; nutrition disorders Sodium retention Eye disorders Proliferative retinopathy; Diabetic retinopathy; Visual impairment Skin and subcutaneous Lipodystrophy; tissue disorders Cutaneous amyloidosis General disorders and Injection site reactions Injection site urticaria Injection site administration site inflammation; conditions Injection site pain; Injection site pruritus; Injection site erythema; Injection site swelling
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-03-05T14:48:00Z · SHA-256 361eee512a62ae9d440e9dc3368e92bfdf642f50b791ed122087c5b884c15e02 · Passage 5827d8786393e93273d0d39bd5039c24e3cef5fd5f1f0114fb5ec07cc32b9c3f · Zeichen 880–3186 im Abschnitt